rawfin.tv
Kymera Therapeutics Files Form 4 on July 27
RegulationstocksAI Generated

Kymera Therapeutics Files Form 4 on July 27

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Kymera Therapeutics Inc (KYMR) has submitted a Form 4 filing with the SEC, dated July 27. This regulatory document typically discloses changes in beneficial ownership of company securities by insiders.

KYMRForm 4SEC FilingInsider TradingBiotechnology

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks